Olmesartan Medoxomil/Amlodipine Besilate/Hydrochlorothiazide Tablets 5/20/12.5 mg

Adult dose

This medication should be taken once daily as one tablet with water, regardless of meals. It is recommended to take it at the same time daily (e.g., in the morning). The recommended dosage is as follows: - 5/20/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with 5/20 mg combination therapy of amlodipine and olmesartan medoxomil. - 5/40/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with 5/40 mg combination therapy of amlodipine and olmesartan medoxomil.

Child dose

The safety and efficacy for pediatric patients under 18 years of age have not been established, so the use of this medication is not recommended.

This medication may cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients in this medication or similar drugs, pregnant or breastfeeding individuals, and those with severe hypotension or problems with heart and kidney function should not take this medication. Patients with low blood volume or compromised kidney function may experience side effects like hypotension, so it is essential to check their condition adequately before taking this medication. Patients with poor liver function, certain heart conditions, or electrolyte imbalances should take this medication with caution and have regular examinations as directed by their physician. Since this medication can lower blood pressure, it may cause dizziness or drowsiness, so caution is advised when driving or operating dangerous machinery. During the use of this medication, the skin may become sensitive to sunlight, so avoiding sun exposure or using sunscreen is recommended. Breastfeeding individuals are advised to avoid taking this medication or discontinue breastfeeding. It is not advisable to administer this medication to children under 18, as its safety has not been established. Elderly individuals may experience stronger effects or side effects due to reduced kidney and liver function, so starting at a lower dose and taking it cautiously is recommended. In case of overdose, severe hypotension or heart function abnormalities may occur, so the dosage must be strictly adhered to, and immediate medical attention should be sought if abnormal symptoms appear. This medication may interact with lithium, certain anti-inflammatory pain relievers, and other blood pressure medications, so it is essential to consult with a doctor or pharmacist if other medications are being taken. Regular blood tests and kidney function tests are necessary, and if symptoms of electrolyte imbalance (muscle cramps, weakness, palpitations, etc.) occur, they should be reported immediately. If skin or eye abnormalities occur while taking this medication, healthcare professionals should be informed immediately.

Serious side effects

Urticaria, severe swelling (edema), difficulty breathing, jaundice, severe allergic reactions, severe skin abnormal reactions, serious neurological symptoms, severe swelling or urinary abnormalities, Stevens-Johnson Syndrome, anaphylaxis, thrombosis, embolism, acute kidney failure, pulmonary edema, acute respiratory distress syndrome (ARDS), vasculitis (including necrotizing vasculitis), intestinal vascular edema, thrombocytopenia, leukopenia, neutropenia/agranulocytosis

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It should be kept at room temperature between 1 to 30 degrees Celsius to maintain its efficacy for a longer duration.

Appearance

White and orange round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu × 3)